JP2023145481A5 - - Google Patents

Info

Publication number
JP2023145481A5
JP2023145481A5 JP2023111632A JP2023111632A JP2023145481A5 JP 2023145481 A5 JP2023145481 A5 JP 2023145481A5 JP 2023111632 A JP2023111632 A JP 2023111632A JP 2023111632 A JP2023111632 A JP 2023111632A JP 2023145481 A5 JP2023145481 A5 JP 2023145481A5
Authority
JP
Japan
Prior art keywords
compound
xrd
crystals
irradiated
light source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023111632A
Other languages
English (en)
Japanese (ja)
Other versions
JP7773506B2 (ja
JP2023145481A (ja
Filing date
Publication date
Priority claimed from JP2020068458A external-priority patent/JP7352509B2/ja
Application filed filed Critical
Publication of JP2023145481A publication Critical patent/JP2023145481A/ja
Publication of JP2023145481A5 publication Critical patent/JP2023145481A5/ja
Application granted granted Critical
Publication of JP7773506B2 publication Critical patent/JP7773506B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023111632A 2016-06-17 2023-07-06 ジフェニルメタン誘導体の製造方法 Active JP7773506B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2016-0075910 2016-06-17
KR20160075910 2016-06-17
JP2020068458A JP7352509B2 (ja) 2016-06-17 2020-04-06 ジフェニルメタン誘導体の製造方法
JP2021102648A JP7669206B2 (ja) 2016-06-17 2021-06-21 ジフェニルメタン誘導体の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021102648A Division JP7669206B2 (ja) 2016-06-17 2021-06-21 ジフェニルメタン誘導体の製造方法

Publications (3)

Publication Number Publication Date
JP2023145481A JP2023145481A (ja) 2023-10-11
JP2023145481A5 true JP2023145481A5 (enExample) 2025-09-26
JP7773506B2 JP7773506B2 (ja) 2025-11-19

Family

ID=60664449

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018565754A Active JP6763978B2 (ja) 2016-06-17 2017-06-15 ジフェニルメタン誘導体の製造方法
JP2020068458A Active JP7352509B2 (ja) 2016-06-17 2020-04-06 ジフェニルメタン誘導体の製造方法
JP2021102648A Active JP7669206B2 (ja) 2016-06-17 2021-06-21 ジフェニルメタン誘導体の製造方法
JP2023111632A Active JP7773506B2 (ja) 2016-06-17 2023-07-06 ジフェニルメタン誘導体の製造方法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2018565754A Active JP6763978B2 (ja) 2016-06-17 2017-06-15 ジフェニルメタン誘導体の製造方法
JP2020068458A Active JP7352509B2 (ja) 2016-06-17 2020-04-06 ジフェニルメタン誘導体の製造方法
JP2021102648A Active JP7669206B2 (ja) 2016-06-17 2021-06-21 ジフェニルメタン誘導体の製造方法

Country Status (29)

Country Link
US (2) US10640496B2 (enExample)
EP (2) EP3663292B1 (enExample)
JP (4) JP6763978B2 (enExample)
KR (2) KR102233229B1 (enExample)
CN (2) CN113651803B (enExample)
AU (1) AU2017285813B2 (enExample)
CA (2) CA3026756C (enExample)
CL (1) CL2018003645A1 (enExample)
CO (1) CO2018014018A2 (enExample)
DK (2) DK3663292T3 (enExample)
DO (1) DOP2018000287A (enExample)
EC (1) ECSP19000185A (enExample)
ES (2) ES2891825T3 (enExample)
HR (1) HRP20211670T8 (enExample)
HU (1) HUE056428T2 (enExample)
MA (2) MA50774B1 (enExample)
MX (2) MX392177B (enExample)
MY (1) MY203941A (enExample)
NZ (1) NZ749398A (enExample)
PE (2) PE20190467A1 (enExample)
PH (1) PH12018550206A1 (enExample)
PL (2) PL3473621T3 (enExample)
PT (2) PT3473621T (enExample)
RS (1) RS62550B1 (enExample)
SA (2) SA521422474B1 (enExample)
SG (2) SG11201811154QA (enExample)
SI (1) SI3663292T1 (enExample)
TN (1) TN2018000437A1 (enExample)
WO (1) WO2017217792A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011054773A1 (de) 2011-10-25 2013-04-25 Vb Autobatterie Gmbh & Co. Kgaa Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols
PE20211206A1 (es) * 2018-08-13 2021-07-05 Dae Woong Pharma Preparacion de intermedio util para la sintesis de inhibidor de sglt
CN112341416A (zh) * 2019-08-09 2021-02-09 天津津艺医药科技发展有限责任公司 一种制备苯并含氧脂杂环衍生物的方法
WO2021172955A1 (ko) * 2020-02-27 2021-09-02 주식회사 대웅제약 Sglt 저해제의 합성에 유용한 중간체 및 이를 이용한 sglt 저해제의 제조 방법
US12448360B2 (en) * 2020-09-10 2025-10-21 Daewoong Pharmaceutical Co., Ltd. Synthesis method for preparing SGLT inhibitor intermediate
CN112094253B (zh) * 2020-09-10 2023-01-10 株式会社大熊制药 用于制备sglt抑制剂中间体的合成方法
CN113200860B (zh) * 2021-04-29 2024-07-30 爱斯特(成都)生物制药股份有限公司 一种sglt2抑制剂中间体的制备方法
KR20230046784A (ko) * 2021-09-30 2023-04-06 주식회사 대웅제약 이나보글리플로진을 포함하는 약학 조성물
CN113801010A (zh) * 2021-11-18 2021-12-17 山东诚创蓝海医药科技有限公司 一种5-溴-2-氯苯甲酸的制备方法
CN113912487B (zh) * 2021-11-23 2024-05-28 山东研峰新材料科技有限公司 一种2,5-双卤代苯甲酸的合成方法
KR20230110001A (ko) * 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법
KR20240044190A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법
KR20240044194A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 공결정
CN119968202A (zh) 2022-09-29 2025-05-09 株式会社大熊制药 用于预防或治疗心血管衰老疾病的包含依那格列净的药物组合物
KR20240047952A (ko) 2022-10-05 2024-04-12 주식회사 대웅제약 이나보글리플로진을 포함하는 신장애 및/또는 당뇨병 예방 또는 치료용 약학 조성물
EP4631498A1 (en) 2022-12-21 2025-10-15 Daewoong Therapeutics Inc. Eye drop-type pharmaceutical composition containing envogliflozin
KR20240107660A (ko) 2022-12-30 2024-07-09 주식회사 대웅제약 이나보글리플로진 및 메트포르민을 포함하는 약학 조성물
KR102853437B1 (ko) * 2024-11-13 2025-09-04 대웅바이오(주) 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102837948B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) 분배 투입법을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102837941B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) Inline quenching 공정을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
EP2514756B1 (en) * 2003-08-01 2014-12-17 Mitsubishi Tanabe Pharma Corporation Novel compounds having inhibitory activity against sodium-dependant glucose transporter
WO2009014970A1 (en) 2007-07-26 2009-01-29 Lexicon Pharmaceuticals, Inc. Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
WO2010012789A1 (en) 2008-07-30 2010-02-04 Ferrer Internacional S. A. 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
WO2012041898A1 (en) 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
KR101576589B1 (ko) * 2011-06-01 2015-12-10 주식회사 녹십자 Sglt2 억제제로서의 신규한 다이페닐메탄 유도체
US9340521B2 (en) 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Similar Documents

Publication Publication Date Title
JP2023145481A5 (enExample)
HRP20211670T1 (hr) Derivat difenilmetana u kristalnom obliku
JP2020511467A5 (enExample)
JP2022088524A5 (enExample)
JP2012067131A5 (enExample)
JP2007519721A5 (enExample)
JP2008517710A5 (enExample)
JP2012256444A5 (enExample)
Gnanam et al. Synthesis of tin oxide nanoparticles by sol–gel process: effect of solvents on the optical properties
JP2010523692A5 (enExample)
JP2025111617A5 (enExample)
JP2010534643A5 (enExample)
JP2021514967A5 (enExample)
RU2019130768A (ru) Способ получения твердого электролита на основе lgps
JP2005504649A5 (enExample)
JP2013000773A5 (enExample)
JPWO2021220648A5 (enExample)
CN109925024A (zh) 角度可调式髓核钳
JP2004502684A5 (enExample)
EA202092393A1 (ru) Кристаллическое соединение оксазола
JP2011508779A5 (enExample)
JP2015506941A5 (enExample)
CN103925312A (zh) 双向棘轮机构
JP2019203007A5 (enExample)
EP4371617A3 (en) Crystal